Johnston SRD - Search Results

1

Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.

Chan A, Moy B, Mansi J, Ejlertsen B, Holmes FA, Chia S, Iwata H, Gnant M, Loibl S, Barrios CH, Somali I, Smichkoska S, Martinez N, Alonso MG, Link JS, Mayer IA, Cold S, Murillo SM, Senecal F, Inoue K, Ruiz-Borrego M, Hui R, Denduluri N, Patt D, Rugo HS, Johnston SRD, Bryce R, Zhang B, Xu F, Wong A, Martin M; ExteNET Study Group. Chan A, et al. Among authors: johnston srd. Clin Breast Cancer. 2021 Feb;21(1):80-91.e7. doi: 10.1016/j.clbc.2020.09.014. Epub 2020 Oct 6. Clin Breast Cancer. 2021. PMID: 33183970 Free article. Clinical Trial.

2

Clinical and endocrine effects of the oral aromatase inhibitor vorozole in postmenopausal patients with advanced breast cancer.

Johnston SR, Smith IE, Doody D, Jacobs S, Robertshaw H, Dowsett M. Johnston SR, et al. Cancer Res. 1994 Nov 15;54(22):5875-81. Cancer Res. 1994. PMID: 7954417 Clinical Trial.

3

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer.

Ellis PA, Saccani-Jotti G, Clarke R, Johnston SR, Anderson E, Howell A, A'Hern R, Salter J, Detre S, Nicholson R, Robertson J, Smith IE, Dowsett M. Ellis PA, et al. Int J Cancer. 1997 Aug 7;72(4):608-13. doi: 10.1002/(sici)1097-0215(19970807)72:4<608::aid-ijc10>3.0.co;2-7. Int J Cancer. 1997. PMID: 9259399 Free article. Clinical Trial.

4

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma.

Johnston SR, Constenla DO, Moore J, Atkinson H, A'Hern RP, Dadian G, Riches PG, Gore ME. Johnston SR, et al. Br J Cancer. 1998 Apr;77(8):1280-6. doi: 10.1038/bjc.1998.214. Br J Cancer. 1998. PMID: 9579834 Free PMC article. Clinical Trial.

5

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy.

Ellis PA, Smith IE, Detre S, Burton SA, Salter J, A'Hern R, Walsh G, Johnston SR, Dowsett M. Ellis PA, et al. Breast Cancer Res Treat. 1998 Mar;48(2):107-16. doi: 10.1023/a:1005933815809. Breast Cancer Res Treat. 1998. PMID: 9596482

6

Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.

Newby JC, Johnston SR, Smith IE, Dowsett M. Newby JC, et al. Clin Cancer Res. 1997 Sep;3(9):1643-51. Clin Cancer Res. 1997. PMID: 9815855

7

Breast cancer: metastatic.

Johnston S, Stebbing J. Johnston S, et al. Clin Evid. 2002 Jun;(7):1579-602. Clin Evid. 2002. PMID: 12230774 Updated. Review. No abstract available.

8

Breast cancer: metastatic.

Johnston S, Stebbing J. Johnston S, et al. Clin Evid. 2002 Dec;(8):1785-810. Clin Evid. 2002. PMID: 12603970 Updated. Review. No abstract available.

9

Breast cancer (metastatic).

Johnston S, Stebbing J. Johnston S, et al. Clin Evid. 2003 Dec;(10):1975-2002. Clin Evid. 2003. PMID: 15555190 Updated. Review. No abstract available.

10

Mitomycin C, vinblastine and cisplatin (MVP): an active and well-tolerated salvage regimen for advanced breast cancer.

Urruticoechea A, Archer CD, Assersohn LA, Gregory RK, Verrill M, Mendes R, Walsh G, Smith IE, Johnston SR. Urruticoechea A, et al. Br J Cancer. 2005 Feb 14;92(3):475-9. doi: 10.1038/sj.bjc.6602367. Br J Cancer. 2005. PMID: 15685237 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page